-
Company Insights
NewJC Medical, Inc. Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our JC Medical, Inc. Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. JC Medical Inc is a pharmaceutical and healthcare company which is engaged to offer medical devices and other relatedd services. The company is headquartered in Quenzon City, Philippines. GlobalData's Medical Devices company profile report, “JC Medical, Inc. Pipeline Insight and Competitive Landscape, 2024" provides information about the company overview and analysis on their pipeline products. This company profile report...
-
Thematic Analysis
NewAdvertising Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Advertising has been caught up in the artificial intelligence (AI) frenzy and will be one of the industries most disrupted by AI. Generative AI is reshaping advertisers’ practices through tailored, effective ads and dynamic campaigns that evolve according to consumer response. As a result, the relationship between technology, artists, and brands paying for campaigns will profoundly change over the coming years. There is a real concern that advertisers will divert their money into AI-generated art rather than paying artists and...
-
Product Insights
NewQuarterly Packaged Water pricing trends in Russia
Empower your strategies with our Quarterly Packaged Water pricing trends in Russia report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Posoleucel in Cytomegalovirus (HHV-5) Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Posoleucel in Cytomegalovirus (HHV-5) Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Posoleucel in Cytomegalovirus (HHV-5) Infections Drug Details: Posoleucel (ALVR-105) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Posoleucel in Herpesviridae Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Posoleucel in Herpesviridae Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Posoleucel in Herpesviridae Infections Drug Details: Posoleucel (ALVR-105) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Posoleucel in Epstein–Barr Virus (HHV-4) Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Posoleucel in Epstein–Barr Virus (HHV-4) Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Posoleucel in Epstein–Barr Virus (HHV-4) Infections Drug Details: Posoleucel (ALVR-105)...
-
Company Insights
J C Bamford Excavators Ltd. – Digital Transformation Strategies
JCB Digital Transformation Strategies Overview JC Bamford Excavators (JCB) has been focusing on forging technology partnerships and integrating digital technologies into its products to efficient operations and enhance customer experience. The annual ICT spending of JCB was estimated at $132.7 million in 2023. A major share of this spending is earmarked for acquiring ICT services, software, and hardware from vendors. JCB is a manufacturer and distributor of construction equipment. The company offers services such as sure price, service agreement, repair,...
-
Product Insights
NewGeneralized Seizures – Drugs In Development, 2024
Empower your strategies with our Generalized Seizures – Drugs In Development, 2024 report and make more profitable business decisions. Generalized seizures, are a type of seizure that impairs consciousness and distorts the electrical activity of the whole or a larger portion of the brain. It occurs when the abnormal electrical activity causing a seizure begins in both halves (hemispheres) of the brain at the same time. Generalized seizures occur in various seizure syndromes, including myoclonic epilepsy, familial neonatal convulsions, childhood absence...
-
Product Insights
NewTonic-Clonic (Grand Mal) Seizure – Drugs In Development, 2024
Empower your strategies with our Tonic-Clonic (Grand Mal) Seizure – Drugs In Development, 2024 report and make more profitable business decisions. A tonic-clonic seizure, previously known as a grand mal seizure, is defined as a seizure that has a tonic phase followed by clonic muscle contractions that causes a loss of consciousness and violent muscle contractions. The Tonic-Clonic (Grand Mal) Seizure drugs in development market research report provide comprehensive information on the therapeutics under development for Tonic-Clonic (Grand Mal) Seizure, complete...